Pain Management Specialist Dr. David Maine Provides Osteocool for Patients
Painful metastatic bone tumors affect about 50% of patients with advanced cancers, and up to 30% of patients with spinal metastases receive no relief with radiation, chemotherapy, surgery, etc. Now there is a new device cleared by the U.S. FDA for treating the pain these tumors can cause.
“The OsteoCool device uses high-frequency energy to ablate metastatic spinal tumors to reduce patient pain,” said Dr. David Maine, Director of The Center for Interventional Pain Medicine.
The OsteoCool system uses two water-cooled probes that release heat, but at a controlled lower temperature, to prevent charring. OsteoCool spreads the heat over a region large enough to ablate most metastatic vertebral tumors, as well as any nearby nerve endings that transmit pain signals.
“Temperature-controlled probes are placed through the needles and positioned on either side of the tumor. The temperature is raised for a few minutes, long enough to kill the tumor and any nearby pain sensors, but without harming healthy bone,” Dr. Maine said.
Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on Facebook, Twitter, or call 1-800-MD-Mercy.
Additional Content That Might Interest You